Digestion · 2009 · 21 citations · 0 references
Life SciencesNutritional SciencesPharmacologyCell SignalingGastrointestinal PharmacotherapyInflammationGastrointestinal InflammationGastrointestinal PathophysiologyGastrointestinal PharmacologyMucosal Barrier FunctionMucosal InflammationPeptic Ulcer DiseaseGastrointestinal Mucosal DamageGastroprotective AgentsMucosal ProtectionProstaglandin ActivityProstaglandin E2 BiosynthesisProstaglandin SignalingProstaglandin Synthesis InhibitionSucralfate Therapy
The therapeutic effects of sucralfate on ulcerated gastric and duodenal mucosa is well known. There is, however, very little information about its effect on the mucosa of the small intestine. We studied the possible protective effect of sucralfate against indomethacin-induced intestinal ulceration in the rat. Sucralfate was found to possess a marked protective effect on the intestinal mucosa (ulcer index 23.16 +/- 6.58 vs. 225 +/- 36.37; p less than 0.001). Sucralfate elevated basal mucosal prostaglandin E2 generation (p less than 0.001), and partially overcame the inhibition of prostaglandin E2 synthesis caused by indomethacin (p less than 0.03), but had no effect on mucosal cAMP level. The effect of sucralfate on prostaglandin E2 content might partially explain its protective effect on the intestinal mucosa.